Punch Technologies, Johnson Controls to make safety communication tech
Category: #business  By Pankaj Singh  Date: 2019-07-27
  • share
  • Twitter
  • Facebook
  • LinkedIn

Punch Technologies, Johnson Controls to make safety communication tech

Johnson Controls will be the exclusive vendor of PunchAlert, developed by Punch Technologies.

North Carolina-based software company, Punch Technologies, Inc. and Johnson Controls have recently finalized a deal to bring a state-of-the-art safety communication system to the market. According to sources, the platform, which can be integrated into businesses’ existing security systems, will offer emergency responders, employees and other surrounding businesses an opportunity to effectively and easily communicate during an emergency.

Speaking on the move, Greg Artzt, Co-founder & Chief Executive Officer, Punch Technologies, said that the company’s partnership with Johnson Controls is a landmark opportunity to partner with an international leader in safety. He said that the company will strengthen its relationship by delivering safety communication to a wide range of private and public enterprises, communities and campuses.

Reportedly, Hank Monaco, V.P, Marketing, Johnson Controls, said that it is essential for businesses to have the necessary tools to broadcast emergency procedures and plans to building occupants and employees.

He claims that this agreement would further Johnson Controls’ commitment towards public safety by providing businesses a mechanism to react and report to emergencies as well as means to improve their security systems and safety rules.

Launched in 2014, PunchAlert is a mobile security and emergency communication app that has gathered immense traction in Canada and the United States with public and private organizations. The PunchAlert platform is developed to resolve customer pain points based on information gained from partners.

Johnson Controls is a global leader focused on creating a comfortable, safe and sustainable world. With a workforce of 105,000 employees, the company develops intelligent buildings, integrated infrastructure and efficient energy solutions that work seamlessly to deliver on its commitment of developing communities and smart cities in 150 countries.

According to reliable reports, Punch Technologies has further revealed plans to launch Rescue, a state-of-the-art safety wearable, in Q1 2020. 

Source Credit: https://www.globenewswire.com/news-release/2019/07/25/1888431/0/en/Johnson-Controls-and-Punch-Technologies-Inc-Collaborate-to-Deliver-Safety-Communication-Technology.html

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Pankaj Singh    

Pankaj Singh

With an experience as an insurance underwriter and a freelance writer under his belt, Pankaj Singh boasts of quite some expertise in the field of content creation. A qualified Post Graduate in Management, Pankaj has also completed a detailed course in Digital Marketin...

Read More

More News By Pankaj Singh

CoSara receives Indian regulatory authorization for its five IVDs
CoSara receives Indian regulatory authorization for its five IVDs
By Pankaj Singh

Co-Diagnostics, a renowned US-based molecular diagnostics company, having a patented, unique platform to develop diagnostics tests reportedly announced that CoSara Diagnostics, the company’s JV for production, has received regulatory clearance ...

U.S. government could issue new rules to block shipments to Huawei
U.S. government could issue new rules to block shipments to Huawei
By Pankaj Singh

  Trump administration had issued 75 licenses to allow Huawei suppliers to resume sales U.S. Commerce Department and other authorities focused on utilizing De minimis Rule The U.S. government is reportedly considering new policies to restr...

Cinda finalizes Phase I study of anti-PD-1 / HER2 bispecific antibody
Cinda finalizes Phase I study of anti-PD-1 / HER2 bispecific antibody
By Pankaj Singh

Cinda Biopharmaceutical, a startup that focuses on treating autoimmune and metabolic diseases, has recently announced the completion of its Phase I clinical study of human epidermal growth factor receptor-2 (HER2) and antibodies against programmed de...